Engineering Advanced In Vitro Models of Systemic Sclerosis for Drug Discovery and Development.
Engineering Advanced In Vitro Models of Systemic Sclerosis for Drug Discovery and Development.
复制标题
用于药物发现和开发的系统性硬化症的工程高级体外模型。
DOI:
10.1002/adbi.202000168
复制
发表时间:
2021-04
期刊:
影响因子:
3.7
通讯作者:
Wuertz-Kozak K
中科院分区:
文献类型:
--
作者:
De Pieri A;Korman BD;Jüngel A;Wuertz-Kozak K
Systemic sclerosis (SSc) is a complex multisystem disease with the highest case-specific mortality among all autoimmune rheumatic diseases, yet without any available curative therapy. Therefore, the development of novel therapeutic antifibrotic strategies that effectively decrease skin and organ fibrosis is needed. Existing animal models are cost-intensive, laborious and do not recapitulate the full spectrum of the disease and thus commonly fail to predict human efficacy. Advanced in vitro models, which closely mimic critical aspects of the pathology, have emerged as valuable platforms to investigate novel pharmaceutical therapies for the treatment of SSc. This review focuses on recent advancements in the development of SSc in vitro models, sheds light onto biological (e.g., growth factors, cytokines, coculture systems), biochemical (e.g., hypoxia, reactive oxygen species) and biophysical (e.g., stiffness, topography, dimensionality) cues that have been utilized for the in vitro recapitulation of the SSc microenvironment, and highlights future perspectives for effective drug discovery and validation.
登录
查看更多内容
影响因子:
6.5
作者:
Achterberg, Volker F.;Buscemi, Lara;Hinz, Boris
通讯作者:
Hinz, Boris
影响因子:
5.6
作者:
Abdullah, Araz S.;Turo, Chala;Zerihun, Ayalsew
通讯作者:
Zerihun, Ayalsew
影响因子:
2.1
作者:
Antonelli, A.;Ferri, C.;Fallahi, P.
通讯作者:
Fallahi, P.
影响因子:
16.1
作者:
Baues M;Dasgupta A;Ehling J;Prakash J;Boor P;Tacke F;Kiessling F;Lammers T
通讯作者:
Lammers T
影响因子:
4.6
作者:
Ahmed Abdi B;Lopez H;Karrar S;Renzoni E;Wells A;Tam A;Etomi O;Hsuan JJ;Martin GR;Shiwen X;Denton CP;Abraham D;Stratton R
通讯作者:
Stratton R